Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Survivin is a member of the inhibitor of apoptosis protein (IAP) family containing a single baculovirus IAP repeat domain. It is expressed during fetal development but becomes undetectable in terminally differentiated normal adult tissues. We previously reported that survivin and its splicing varian...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Tsuruma, Tetsuhiro, Hata, Fumitake, Torigoe, Toshihiko, Furuhata, Tomohisa, Idenoue, Satomi, Kurotaki, Takehiro, Yamamoto, Masaaki, Yagihashi, Atsuhito, Ohmura, Tosei, Yamaguchi, Koji, Katsuramaki, Tadashi, Yasoshima, Takahiro, Sasaki, Kazuaki, Mizushima, Yasuhiro, Minamida, Hidetoshi, Kimura, Hiromichi, Akiyama, Morifumi, Hirohashi, Yoshihiko, Asanuma, Hiroko, Tamura, Yasuaki, Shimozawa, Kumiko, Sato, Noriyuki, Hirata, Koichi
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2004
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC446218/
https://ncbi.nlm.nih.gov/pubmed/15193151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-2-19
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы